AKTX · Akari Therapeutics Plc
$8.46
-0.24 (-2.70%)
At close · Jul 27
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least a one-year period following the issuance of these condensed consolidated financial statements.”View the 10-Q filed May 19, 2026
Market Cap
$14.81M
Shares
1.75M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 209 | $9.69 | $2,025 |
| 2026-06-23 | 1,592 | $11.23 | $17,878 |
| 2026-06-22 | 1,589 | $10.94 | $17,384 |
| 2026-06-18 | 658 | $12.00 | $7,896 |
| 2026-06-09 | 820 | $15.45 | $12,669 |
| 2026-06-05 | 4,122 | $15.84 | $65,292 |
| 2026-06-04 | 4,178 | $14.99 | $62,628 |
| 2026-06-03 | 39,884 | $14.63 | $583,503 |
| 2026-06-02 | 61,976 | $13.43 | $832,338 |
| 2026-06-01 | 72,483 | $16.43 | $1,190,896 |
| 2026-05-29 | 64,363 | $22.05 | $1,419,204 |
| 2026-05-28 | 81,344 | $15.93 | $1,295,810 |
| 2026-05-27 | 58,507 | $17.81 | $1,042,010 |
| 2026-05-26 | 258,590 | $18.27 | $4,724,439 |
| 2026-05-22 | 208,544 | $5.14 | $1,071,916 |
| 2026-05-21 | 7,125 | $3.74 | $26,648 |
| 2026-05-20 | 5,742 | $3.74 | $21,475 |
| 2026-05-19 | 622 | $3.59 | $2,233 |
| 2026-05-15 | 9,934 | $3.70 | $36,756 |
| 2026-05-14 | 2,820 | $3.15 | $8,883 |
| 2026-05-13 | 3,145 | $3.06 | $9,624 |
| 2026-05-01 | 41 | $5.35 | $219 |
| 2026-04-28 | 102 | $5.60 | $571 |
Showing 1–23 of 23 settlements